Requirement of tumor-associated antigen-specific CD4 + T cells for an efficient dendritic cell vaccine in antitumor immunotherapy

By Simon Thomas   Fonteneau Jean-François   Grégoire Marc  

Immunotherapy, Vol. 5, Iss. 6, 2013-06 ,pp. : 565-567

Future Medicine

Access to resources Recommend Favorite

4-1BB co-stimulation enhances human CD8 + T cell priming by augmenting the proliferation and survival of effector CD8 + T cells

By Laderach D.  

International Immunology, Vol. 14, Iss. 10, 2002-10 ,pp. : 1155-1167

Oxford University Press

Access to resources Recommend Favorite

Ag-Specific Type 1 CD8 Effector Cells Enhance Methotrexate-Mediated Antitumor Responses by Modulating Endogenous CD49b-Expressing CD4 and CD8 T Effector Cell Subpopulations Producing IL-10

By Dobrzanski Mark   Reome Joyce   Hylind James   Rewers-Felkins Kathleen   Abdulsamad Khaliquzzaman   Adams Shawna  

Immunological Investigations, Vol. 37, Iss. 4, 2008-05 ,pp. : 315-338

Informa Healthcare

Access to resources Recommend Favorite

Direct demonstration of CD4 T cell cooperation in the primary in vivo generation of CD4 effector T cells

By Kroeger David R.   Rudulier Christopher D.   Peters Nathan C.   Bretscher Peter A.  

International Immunology, Vol. 24, Iss. 8, 2012-08 ,pp. : 519-527

Oxford University Press

Access to resources Recommend Favorite

Induction of tumor-specific T cell response by cognating tumor cells with foreign antigen-primed t h cells

By Lin R-H.   Cheng T-Y.   Wu J-T.  

International Immunology, Vol. 10, Iss. 10, 1998-10 ,pp. : 1397-1406

Oxford University Press

Access to resources Recommend Favorite